Oregon Public Employees Retirement Fund’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-17,884
Closed -$118K – 1695
2023
Q2
$118K Sell
17,884
-800
-4% -$5.13K ﹤0.01% 1665
2023
Q1
$127K Sell
18,684
-50
-0.3% -$352 ﹤0.01% 1655
2022
Q4
$138K Buy
18,734
+204
+1% +$1.99K ﹤0.01% 1644
2022
Q3
$183K Hold
18,530
– – ﹤0.01% 1579
2022
Q2
$202K Sell
18,530
-2,140
-10% -$22.2K ﹤0.01% 1408
2022
Q1
$234K Sell
20,670
-500
-2% -$6.57K ﹤0.01% 1599
2021
Q4
$332K Sell
21,170
-1,000
-5% -$17.4K ﹤0.01% 1415
2021
Q3
$380K Sell
22,170
-100
-0.4% -$1.75K ﹤0.01% 1383
2021
Q2
$479K Hold
22,270
– – 0.01% 1322
2021
Q1
$334K Buy
22,270
+400
+2% +$6.47K ﹤0.01% 1439
2020
Q4
$287K Sell
21,870
-344
-2% -$4.14K ﹤0.01% 1422
2020
Q3
$215K Buy
22,214
+1,100
+5% +$11.8K ﹤0.01% 1396
2020
Q2
$242K Hold
21,114
– – ﹤0.01% 1350
2020
Q1
$219K Hold
21,114
– – ﹤0.01% 1317
2019
Q4
$346K Hold
21,114
– – ﹤0.01% 1333
2019
Q3
$280K Buy
21,114
+400
+2% +$5.58K ﹤0.01% 1444
2019
Q2
$292K Buy
20,714
+400
+2% +$6.37K ﹤0.01% 1440
2019
Q1
$374K Buy
20,314
+367
+2% +$8.36K 0.01% 1360
2018
Q4
$521K Buy
+19,947
New +$469K 0.01% 1199

Other funds holding VNDA

Oregon Public Employees Retirement Fund's VNDA Position: Q3 2023 in Review

Oregon Public Employees Retirement Fund sold out of Vanda Pharmaceuticals (VNDA) in Q3 2023, closing a stake of 17,884 shares — an estimated $118K sold.

Oregon Public Employees Retirement Fund first reported a position in VNDA in Q4 2018 and held it in 19 quarters. The position peaked at $521K in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q3 2023.

  • Oregon Public Employees Retirement Fund reported no remaining Vanda Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Oregon Public Employees Retirement Fund sold 17,884 Vanda Pharmaceuticals shares in Q3 2023, an estimated $118K.
  • Oregon Public Employees Retirement Fund first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 19 quarters.
  • Oregon Public Employees Retirement Fund's Vanda Pharmaceuticals position peaked at $521K in Q4 2018.
  • 179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2023.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q3 2023, filed 27 Oct 2023.